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Abstract
Pannexin1 (Panx1) forms large nonselective membrane channel that is implicated in paracrine and inflammatory signaling.
In vitro experiments suggested that Panx1 could play a key role in ischemic death of hippocampal neurons. Since retinal
ganglion cells (RGCs) express high levels of Panx1 and are susceptible to ischemic induced injury, we hypothesized that
Panx1 contributes to rapid and selective loss of these neurons in ischemia. To test this hypothesis, we induced experimental
retinal ischemia followed by reperfusion in live animals with the Panx1 channel genetically ablated either in the entire
mouse (Panx1 KO), or only in neurons using the conditional knockout (Panx1 CKO) technology. Here we report that two
distinct neurotoxic processes are induced in RGCs by ischemia in the wild type mice but are inactivated in Panx1KO and
Panx1 CKO animals. First, the post-ischemic permeation of RGC plasma membranes is suppressed, as assessed by dye
transfer and calcium imaging assays ex vivo and in vitro. Second, the inflammasome-mediated activation of caspase-1 and
the production of interleukin-1b in the Panx1 KO retinas are inhibited. Our findings indicate that post-ischemic neurotoxicity
in the retina is mediated by previously uncharacterized pathways, which involve neuronal Panx1 and are intrinsic to RGCs.
Thus, our work presents the in vivo evidence for neurotoxicity elicited by neuronal Panx1, and identifies this channel as a
new therapeutic target in ischemic pathologies.
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Introduction
Neuronal ischemia caused by the loss of blood supply to the
brain or retina leads to ATP depletion, followed by the inhibition
of Na+/K+ pumps, the collapse of membrane potential and global
ionic disregulation [1,2]. Physiological studies have suggested
ionotropic glutamate and kainate receptors [3,4,5], calcium
channels [6,7] and, more recently, hemichannels [8,9] to be
implicated in these pathological events. Pannexin1 protein,
encoded by the Panx1 gene, is a mammalian membrane
channel-forming protein structurally and evolutionary related to
invertebrate gap junction proteins [10,11,12]. Whereas gap
junction full channels coordinate electric and metabolic activity
of contacting cells via full channels, their half-channels (hemi-
channels) communicate the intra- and extracellular compartments
and serve as a diffusional pathway for ions and small molecules
[13]. Pannexins form membrane channels incapable of coupling
into functional gap junctions [14], which distinguishes them from
connexins [15].
The Panx1 channel has high electrical conductance and is
permeable to small molecules and metabolites including ATP, IP3,
LPS, NAD+,C a
2+, glucose, glutamate, arachidonic acid and
glutathione among others [15]. This channel opens in response to
membrane depolarization and increase in cytosolic Ca
2+, while its
interactions with various membrane receptors render Panx1
responsive to mechanical stimulation, extracellular purines, high
extracellular K
+, and other stimuli [11,15,16,17,18]. A more
recent study showed proteolytic activation of Panx1 by caspase-3
digestion and indicated that the channel plays an essential role in
phagocyte attraction during apoptosis [19]. Currently, the normal
physiological function of Panx1 remains poorly understood. It was
shown that cell swelling and membrane breakdown after ischemic
injury are blocked by hemichannel inhibitors in pyramidal
neurons, which express Panx1 but not connexins [8,20]. These
data, together with the findings that Panx1 channels are opened by
extracellular ATP [17], nitric oxide [20] and glutamate [21],
suggested that Panx1 activation facilitates neurotoxicity in
ischemic brain [9].
Panx1 is also involved in the activation of a cytoplasmic protein
complex known as the inflammasome. The inflammasome
mediates proteolytic activation of caspases-1, which is a critical
step in processing and secretion of pro-inflammatory cytokines IL-
1b, IL-18 and IL-33 in monocytes, astrocytes, as well as brain
neurons [22,23]. Over-production of IL-1b was shown to play
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inflammasome activation is now being implicated in multiple
neurological conditions [25], including brain and spinal cord
injury [26,27]. The IL-1b toxicity can be suppressed by
interleukin-1 receptor blockade, which alleviated damage in
retinal ischemia model [28,29,30]. Anti-IL-1b therapy is now a
clinically proven therapy of autoinflammatory diseases, familial
hereditary fever, gout, rheumatoid arthritis and type 2 diabetes
mellitus [31,32,33] and is in clinical trials for stroke patients [34].
Equally efficient neuroprotection is achieved by alternative
strategy, i.e. by direct blockade of inflammasome, as shown in
rodent models of stroke and traumatic brain injury [26,27]. The
exact nature of signal leading to inflammasome activation in the
CNS remains poorly understood. Among the mechanisms
suggested recently is Panx1 channel-mediated internalization of
external danger signals [35,36] and Panx1-mediated activation of
caspase-1 [23,37]. However, the connection between neuronal
Panx1 channel and molecular underpinnings of ischemic degen-
eration of neurons remains to be investigated.
The overall aim of this study is to examine the role of Panx1
channels in the pathophysiology of retinal IR injury in vivo. The
hemichannel blockers such as carbenoxolone (CBX), lanthanum
and mefloquine that were commonly utilized to study the function
of Panx1 in cultured cells are not suitable for this purpose. These
chemicals are rather non-specific as they also inhibit connexons
and stimulate unrelated pathways. To circumvent potential non-
specific effects commonly associated with pharmacological inhib-
itors, we developed a conditional Panx1 knockout mouse. This
mouse model was instrumental to study the relationship between
Panx1 activity and pathophysiology of ischemic loss of RGCs in
the retina. We report here that Panx1 deficiency protects RGCs
from death induced by ischemia. Our data provide evidence that
Panx1 is involved in at least two toxicity mechanisms and suggest
that Panx1 is a convergence point for several neurotoxic pathways
and a new target for therapeutic intervention in retinal ischemic
disorders.
Results
Panx1 conditional knockout mouse line
To study the role of Panx1 channels in retinal ischemia we
generated homozygous Panx1fl/fl (‘‘floxed’’) mutant mice, har-
boring three LoxP consensus sites inserted into a single-copy Panx1
gene (Panx1/LoxP line, Fig. S1). Founders with germline
transmission of ES cell-derived genome were heterozygous for
the mutant Panx1allele and were bred for homozygocity. The
resulting mice were crossed with CMV-Cre and Thy1-Cre strains
to create the global KO (CMV-Cre/Panx1) and neuron-specific
conditional CKO (Thy1-Cre/Panx1) knockout lines. Cre-mediated
recombination within the Panx1 gene resulted in a germline
removal of the LoxP-flanked exons 3 and 4. These two lines were
backcrossed to C57Bl/6 background for at least five generations
and bred to homozygocity afterwards.
Disruption of the gene and the transcript was confirmed by
Southern blot, RT-PCR and partial genome sequencing (Fig. 1A
and Fig. S1). Panx1 protein ablation was validated by Western blot
and immunohistochemistry (IHC) in the Panx1 KO retinas
(Fig. 1B,E) using mouse monoclonal anti-Panx1 CT-395 antibod-
ies [38], and with two other commercially available antibodies
(Fig. S2). Both the conditional and global Panx1 knockouts were
Figure 1. Analysis of Panx1 ablation in CMV-cre/Panx1 (KO) mouse retinas. A. RT-PCR analysis of retinal and brain homogenates from wild
type (WT), Panx1 CKO (CKO) and Panx1 KO (KO) mice using primers for the floxed Exon 4 (287 bp band, arrow). B. Western blot analysis of total retina
homogenates probed with rabbit anti-Panx1 CT-395(Px-34) antibodies [38] shows a 47 kDA band (arrow) corresponding to Panx1. C. Quantitative RT-
PCR analysis of relative abundance of Panx1 transcripts in total retinal extracts from the animals of all three genotypes. D. Relative abundance of
Panx1 and Panx2 transcripts in total extracts from WT, CKO and KO retinas. The values were normalized to the levels of Actb (b-actin), with the data
presented as mean6SD. Double asterisk indicates P,0.01. E. Confocal micrographs of retinal sections from WT and KO mice probed with anti-Panx1
CT-395 antibodies (red) and co-labeled with RGCs marker Neuronal Class III b-Tubulin (green), and nuclei marker DAPI (blue). RGC somatae with
Panx1-specific labeling are indicated by arrows. Scale bar, 25 mm. F. Relative abundance of Panx1, Panx2 and Cx36 transcripts the WT, CKO and KO
retinas. Transcript abundances were normalized to the levels of Actb; data are presented as mean6SD. Double asterisk indicates P,0.01.
doi:10.1371/journal.pone.0031991.g001
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morphology, RGC density and presence of a- and b-waves of
standard flash electroretinograms (Table S1; Fig. S3).
According to quantitative RT-PCR, neuron-specific Panx1
knockout resulted in a 60% decrease in the abundance of the
Panx1 transcript compared to WT retinas (Fig. 1C). This partial
reduction was expected because Panx1 is also present in non-Thy-
1-expressing neurons, glial and vascular endothelial cells [39,40].
In contrast, the global Panx1 KO line lacked the transcript
entirely. To test whether Panx1 deficiency causes compensatory
changes in other hemichannels, we measured the expression of the
pannexin2 and connexin36 genes, but no statistically significant
changes were detected (Fig. 1 D,F).
IR-induced RGC loss is suppressed by the ablation of
Panx1
Several pathophysiological events of the ischemic CNS injury,
including ionic disbalance, anoxic depolarization and oxidative
stress can be explained by an abrupt permeation of neuronal
plasma membrane [8,20]. Therefore, we hypothesized that a
pathological cascade leading to ischemia-induced RGC loss is
triggered by the opening of Panx1 channels. To test whether this
model is correct, we compared the extent of RGC loss caused by
experimental IR injury in Panx1 KO vs. WT mice. We challenged
retinas in vivo with a 60 minute ischemia followed by reperfusion,
which is an established injury model characterized by selective loss
of RGCs that occurs within 7 days after reperfusion [41,42]. A
separate group of animals were analyzed 14 days after reperfusion
to test whether the Panx1 ablation provides lasting protection,
rather than just delaying neuronal loss. RGC densities were
assessed across the retina using direct counting of ClassIII
b-Tubulin -labeled cells (details in Materials and Methods).
RGC densities in corresponding regions of experimental and
control retinas were compared and RGC loss rates were calculated
for three eccentricity regions of the retina: center, middle and
periphery. Protection by the Panx1 ablation was rather even
across the retina, with only a slight tendency to a decrease at the
periphery (Fig. S4). Therefore, we used averaged RGC loss rates to
compare different genotypes. Our data showed that in the WT
mice, RGC survival in IR-injured retinas averaged 70.360.9% at
7 days after injury. Panx1 knockout strains showed significant
increase in neuronal survival 7-days after reperfusion: 98.564%
(p,0.01) in Panx1 CKO and 95.763% (p,0.01) in Panx1 KO
(Fig. 2A,B). At 14 days post-reperfusion, RGC survival was also
significantly higher in Panx1 KO retinas, averaging 93.460.1%
vs. 71.661.6% (p,0.01) in control WT mice. Thus, the absence of
Panx1 protected RGCs from the loss to the IR injury.
We observed no statistically significant difference in RGC
survival in CKO and global KO in IR-challenged retinas (Fig. 1B).
There was even a small trend toward an increased survival in
CKO vs. KO retinas. These findings suggested that Panx1
opening represents an intrinsic mechanism of neuronal death, and
did not involve other cell types. To test this hypothesis, we studied
survival of pan-purified primary RGCs. RGCs were purified from
P7 neonatal mice using the two-step immunopanning technique,
as described previously [43,44] and challenged in vitro with
transient 4 hour-long oxygen and glucose deprivation (OGD).
This model allows for the study of neurons under well controlled
conditions that mimic retinal IR injury, including intracellular
glucose and ATP depletion, an increase in intercellular Ca
2+,E R
and oxidative stress, followed by cell death by necrosis and
apoptosis [45,46]. In line with our prediction, our data showed
Figure 2. Protective effect of Panx1 KO in ischemic retina. A. Representative micrographs of retinas from experimental (post-IR) and control
sham treated (sham) eyes from WT, Panx1 CKO (CKO) and Panx1 KO (KO) animals challenged by retinal IR. RGCs are labeled with Neuronal ClassIII b-
Tubulin antibodies for counting. Scale bar, 50 mm. B. Neuronal survival was calculated as the percentage of cells in experimental vs. fellow sham-
operated eyes (mean6SD, n=8); RGC survival rates were measured at 7 and 14 days after IR using direct cell count in retinal flat-mounts. C. RGC
Survival and the rates of apoptotic and necrotic cells in the OGD-challenged primary RGCs cultures from Panx1 KO and WT retinas 24 h after OGD.
Annexin V/Propidium Iodide (PI) co-labeling was utilized to analyze cell death.
doi:10.1371/journal.pone.0031991.g002
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(p,0.02, Fig. 2 C). The average RGC survival rate was 4662% in
WT cultures. Survival improved by the average of 22% and 29%
in the CKO and KO cells, respectively. It is worth noting that the
difference between the two genotypes was not statistically
significant, indicating that the deficiency of Panx1 in RGCs is,
indeed, responsible for their increased survival. The analysis of
dying cells using AnnexinV and propidium iodide (PI) staining
revealed that necrotic (PI-positive) cells averaged 1660.3% in WT
RGCs cultures; whereas in the CKO and KO culture, this value
has dropped to 4.665% and 0.561%, respectively. Apoptotic
(AnnexinV-positive) cells averaged 4062% in WT vs. 27.463.7%
in Panx1 CKO and 24.462.3% in Panx1 KO cultures challenged
by OGD.
Panx1 channel permeates RGCs challenged by OGD
Panx1 forms a large non-specific pore, which provides the
conduit to ions, dyes and small molecule metabolites with
molecular weight up to 1 kDa [16,47,48]. In isolated brain
neurons, the opening of the Panx1 channel was shown to permeate
the plasma membrane in response to 15 minutes of ischemia
[8,20], thus allowing molecules to cross the plasma membrane
[35,36]. Here, we tested whether a membrane-impermeable dye
calcein-488AM (MW 660 Da) will leak from RGCs challenged by
OGD and if the leakage can be blocked by Panx1 ablation. In the
cytoplasm, this dye is de-esterified, becomes hydrophilic and stays
trapped inside the cell. Opening of a large pore or channel induces
time-dependent exit of the dye from cells, which can be detected
by fluorescence microscopy [8,20].
We loaded whole retina explants with calcein-488 and
measured the leakage after 30 minutes of OGD (de-oxygenized
media lacking glucose) in an ischemic chamber. Each pair of WT
and Panx1 KO retinas was prepared and challenged by OGD in
parallel to avoid technical deviations. After the exposure to OGD,
retinal explants were immediately imaged by confocal microscopy.
The total fluorescence in the 30 mm-thick optical slice of the inner
nuclear layer (INL) was recorded, as detailed in Materials and
Methods. We found that OGD caused an average of 33%
reduction in total fluorescence in the ganglion cell layer that
resulted from dye leakage in WT retinal explants (Fig. 3A). In
contrast, retinas obtained from the Panx1 KO mice showed a
near-complete blockade of the leakage.
The ganglion cell layer contains a mixed population of RGC,
amacrine and glial cells, all of which express different level of
pannexins. Therefore, quantitative analysis of the dye leakage
from an individual cell type is challenging when performed in
retinal explants. To detect whether ganglion cells become
permeated, we performed OGD challenge experiments in primary
cultures of RGCs in vitro. The neurons were pre-loaded with
calcein-488AM were exposed to OGD (de-oxygenized media
lacking glucose with constant N2 bubbling) and dye leakage was
monitored by time-lapse confocal microscopy for 60 minutes.
Real-time imaging of dye-loaded RGCs revealed a rapid
permeation by OGD with a statistically significant drop in
Figure 3. Panx1 KO blocks RGC plasma membrane permeation after ischemia. A Representative confocal images of the ganglion cell layer
in whole retina flat mounts preloaded with calcein-488. Images were taken after 30 min normoxic or OGD treatment in a hypoxic chamber. Scale bar,
25 mm. Graph shows total calcein fluorescence intensity (mean 6 SE, n=4) after treatment of WT or Panx1 KO retinal explants. The reduction of
fluorescence after OGD indicates the dye leakage in WT. B. Real-time confocal images of cultured primary RGCs loaded with calcein-488. Shown are
representative series of three independent experiments. C. The dynamics of calcein-488 dye efflux calculated as the change in fluorescence intensity
recorded from at least 50 individual cells in three independent experiments. D Intracellular Ca
2+ changes were measured in cultured primary RGCs
loaded with ratiometric fura-2 dye. OGD was induced at the ‘‘0’’ time point by replacing culture media with oxygen-depleted glucose-free media
supplemented with 10 mM 2-deoxyglucose and 1 mM KCN. Fluorescence measurements were taken at 510 nm with excitations at 340 and 380 nm
in real time with 20 sec intervals. Traces represent the average values (mean 6 SE) of the 340/380 ratios obtained from a minimum of 30 individual
RGC cells in a minimum of three biological repeats. In WT cells Panx1 blockade was induced by application of 10 mM CBX 20 minutes prior to
recording.
doi:10.1371/journal.pone.0031991.g003
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ischemia (Fig. 3B,C). Using untreated (normoxic) WT RGCs as a
reference to normalize for photobleaching, the calculated rate of
leakage was 19.2% at 15 minutes, 31.6% and 52.5% at 30 and
60 minutes of OGD, respectively. In contrast, the OGD-
challenged Panx1 KO cells showed very slow reduction in
fluorescence that closely matched the effect of photobleaching in
normoxic cells (Figs. 3C). The calculated changes in calcein-488
fluorescence (2.0% at 30 min and 3.6% at 60 min) were not
statistically significant, indicating that the dye remained trapped
inside the OGD-treated Panx1 KO cells.
Next, we investigated whether Panx1 ablation influences
intracellular [Ca
2+]i dynamics in ischemia. We used real-time
ratiometric fura-2 dye measurements in primary cultured RGCs
(Fig. 3D). We found that in WT cells OGD induced a biphasic
increase in intracellular free calcium [Ca
2+]i. The first phase
occurred within 10 min of OGD, while the second phase was
slower and continued for the duration of recording (up to 1 h).
Since both phases were not observed when the cells were perfused
by Ca
2+-free medium, we attributed the [Ca
2+]i increase to the
influx of Ca
2+ across the plasma membrane. In the Panx1 KO
cells the first phase was eliminated and the second phase was
notably suppressed. A similar effect was observed upon treatment
of WT neurons with 10 mM CBX. Thus, Panx1 opening mediates
plasma membrane permeability in ischemic RGCs to small
molecules such as dyes and ions.
Panx1isessentialforinflammasomeactivationintheretina
Panx1 has been shown to directly interact and regulate the
activation of the inflammasome protein complex in the brain
neurons and astrocytes [23,26,27]. However, this remains
controversial, particularly considering the most recent data
published when our manuscript was under review [49]. We
examined transcriptional activation of the Il1b gene, post-
translational activation of interleukin-1b and the key inflamma-
some protease caspase-1 in response to IR. Retinal lysates from
naı ¨ve, IR-challenged and sham-operated contralateral eyes of WT
and Panx1KO mice were analyzed using quantitative PCR,
Western blot and IHC. In addition, we examined the expression of
the other inflammasome components, adaptor protein ASC
(apoptosis-associated speck-like protein containing a CARD) and
NALP1 (NAcht leucine-rich-repeat protein 1) in RGCs. In the
WT retinas harvested at 3 hours after reperfusion, we observed: 1)
a significant increase in the expression of the Il1b gene (Fig. S5), 2)
accumulation of pro-caspase-1 and mature caspase-1 (Fig. 4A,B)
and 3) accumulation the mature IL-1b. An increase in the levels of
both 45 kDa pro-caspase-1 and its 26 kD cleavage product
indicated activation of the inflammasome. Consistently, IHC
showed a dramatic increase in the caspase-1 and IL-1b labeling, a
large proportion of which localized to the cells in the ganglion cell
layer (Fig. 4C). Furthermore, IHC co-localization analysis
performed in primary cultures confirmed that RGCs, indeed,
expressed high levels of caspase-1 and IL-1b after OGD challenge
(Fig. S6). Lower levels of IL-1b immunoreactivity were also found
in other retinal layers, a pattern consistent with the distribution of
secreted proteins (Fig. 4C). The expression of ASC and NALP1
and their co-localization with RGC-specific marker ClassIII b-
Tubulin was also detected by IHC (Fig. S7). However, no
significant induction of the ASC and NALP1 proteins was detected
after IR (data not shown). These observations indicate that robust
activation of inflammasome and IL-1b production is a part of the
acute response of the retina to the IR injury.
Figure 4. Suppression of IL-1b production and inflammasome activation in Panx1 KO retinas. A. The levels of activated caspase-1 and
the mature IL-1b proteins observed 3 h after reperfusion in WT, Panx1 KO (KO) and Panx1 CKO (CKO) retinas. B. Quantification of the changes in band
intensities from western blots in figure A (n=3, ** p,0.05). C. The IHC analysis showing active IL-1b (17 and 20 kDa isoforms, arrowheads) in the cells
of the inner retinal layer (INL) after IR challenge. Caspase1-specific (red) and IL-1b-specific (green) staining co-localized with RGCs and other cells in
the ganglion cell layer (GCL), IL-1b staining also labeled cells in the INL. DAPI staining for nuclei is blue. Scale bar, 50 mm.
doi:10.1371/journal.pone.0031991.g004
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to test if Panx1 is involved in the regulation of inflammasome
activation in IR. We found that activation of all components of the
inflammasome complex was suppressed in the Panx1 KO retinas
and the inhibition was stronger in global Panx1 KO vs. Panx1
CKO animals. Sham-operated fellow eyes showed no statistically
significant changes in inflammasome protein accumulation and
processing. Thus, our results indicate that Panx1 is essential for
inflammasome activation in the IR-challenged inner retina,
particularly in RGCs.
Discussion
In this study, we investigated the role of the Panx1 channel in
the pathophysiology of global retinal ischemia followed by
reperfusion. We have demonstrated that RGCs in Panx1-deficient
animals are remarkably resistant to ischemia, providing strong
evidence that the Panx1channel is an essential player in
pathophysiology of IR injury in neurons. We also identified two
distinct neurotoxic mechanisms that are mediated by Panx1: RGC
membrane permeation to small molecules and ions (Fig. 3) and
activation of the inflammasome (Fig. 4).
Our data also show that the mechanisms of RGC injury in IR
are intrinsic to these neurons and are caused by the opening of the
endogenous Panx1 channels. This notion is supported by three
lines of evidence. First, neuronal Panx1 knockout provided the
same, if not higher, degree of in vivo protection as the global Panx1
ablation (Fig. 2B). Second, primary Panx1-deficient RGCs
possessed increased survival, decreased rates of apoptosis and
near complete suppression of necrosis after exposure to OGD in
vitro (Fig. 2C). Finally, the IHC data show that RGCs, which are
the most vulnerable to ischemia among retinal neurons, possess
the highest levels of Panx1 expression in the retina (Fig. 1, Fig. S2).
The latter is consistent with our earlier report that utilized in situ
hybridization and gene expression analysis in purified primary
RGCs [50].
The role of Panx1 in rapid membrane permeation
induced by ischemia
The role of Panx1 channel opening in the ischemia-induced
membrane permeation was first demonstrated using erythrocytes
and isolated hippocampal neurons [8,20,51]. In those experiments
Panx1 opening occurred within the first 15 min of ischemia.
However, the ability of Panx1 to permeate neurons in vivo
remained controversial after Madri and co-authors [52] showed
that in hippocampal slices Panx1-dependent permeation was
significantly slower (90 vs. 15 min) than in isolated neurons. Our
experiments showed that the average rate of dye leakage from the
ganglion cell layer in the retinal wholemounts was significantly
suppressed in Panx1 KO retinas (Fig. 3A). Similar experiments
performed in real time in cultured primary RGCs showed that
15 minutes of ischemia (OGD) was sufficient for the induction of a
robust Panx1 channel opening; 30 min of ischemia averaged 33%
and 31.6% of total calcein 488 fluorescence reduction ex vivo and in
vitro, respectively.
As expected, the Panx1-mediated permeation of plasma
membrane in oxygen- and glucose-deprived RGCs also altered
ionic homeostasis and increased the rate of [Ca
2+]i accumulation.
Our data showed that the difference between the WT and Panx1
KO RGCs became statistically significant only after 10 minutes of
OGD; only the second phase of Ca
2+ accumulation was blocked by
application of 10 mM CBX or by Panx1 ablation (Figs. 3D). Thus,
our findings are consistent with the model where Panx1 channel-
mediated permeation of the plasma membrane is rapid [8,20,51].
Panx1 mediates neuronal injury in the retinal IR model
We demonstrated that Panx1 in RGCs contributes to
pathophysiology of acute retinal ischemia. The IR injury in the
retina is known to cause a delayed neuronal cell loss, which occurs
several days after primary insult, while secondary degeneration
extends for weeks [41,53,54]. Up to seven days post-reperfusion
the loss is specific to RGCs, while amacrine cells and other
neurons succumb later [41]. Our results showed near-full
protection of RGCs one week after reperfusion in both global
and conditional Panx1 deletion. Furthermore, RGCs remained
protected for as long as 14 days (Fig. 2B), showing that RGC loss is
not merely delayed but actually prevented by Panx1 ablation.
These results are consistent with the reports of neuroprotection by
global pharmacological blockade of hemichannels in brain
ischemia and inflammation models [9,13,54,55]. Thus, Panx1
plays a significant role in ischemic pathology of the retina, which
evidently differs from ischemic stroke in the brain, as reported
recently [49].
Long-term protection implies that in addition to initial acute
injury mediated by rapid Panx1 channel opening, Panx1mediates
a long-acting mechanism(s) of neurotoxicity. One possibility is that
Panx1 activation triggers neurotoxic signaling that facilitates
secondary degeneration. Indeed, several toxicity pathways, such
as [Ca
2+]i accumulation, oxidative ROS production [54],
excitotoxicity [56], necrotic cell signaling [57], TLR-4 signaling
[58] and pro-inflammatory cytokine induction [28,59] were
characterized in post-IR retina. Interestingly, OGD induced
necrosis in the WT RGC cultures but not in Panx1-deficient
neurons (Fig. 2 C). The lack of necrotic cells in post-ischemic
retinas indicates inhibition of necrotic cell signaling, which is a
novel degeneration pathway recently characterized in retinal
ischemia [57,60] and cone-rod dystrophy [61]. Since necrotic
death in the ischemic retina is caused primarily by ATP-depletion
[60], we speculate that the protective effect of Panx1 deletion likely
involves preservation of intracellular ATP levels.
Panx1 is essential for activation of neuronal
inflammasome after IR injury
Our present work shows that the neuronal inflammasome is
activated by retinal IR, as detected by two major markers of
inflammasome activation: caspase-1 proteolysis and production of
the mature IL-1b. We detected a change in the levels of precursor
and mature caspase-1, which signifies the activation of the
inflammasome complex, and the timing of this activation
coincided with the increased expression and processing of IL-1b.
Additional evidence is the expression of inflammasome proteins
ASC and NALP1, detected in RGCs by immunohistochemistry.
Mature IL-1b is released and accumulated in the retina, and the
IHC data show that RGCs are a major inner retina cell type
producing IL-1b. As confirmed by Western blot and co-
localization analysis in the IHC data (Fig. S6), RGCs also show
an increased expression of caspase-1 in response to retinal IR
injury (Fig. 4C). Our findings are consistent by previous reports
that observed IL-1b production [28,43] and increased expression
of caspase-1 in the inner retina of post-ischemic rodent eyes [62].
The major markers of inflammasome activation were considerably
suppressed in the Panx1 KO retinas, indicating that Panx1 is
required for activation of this complex.
Panx1 was previously shown to co-immunoprecipitate with
components of NALP1-containing inflammasome [63] and to be
involved in regulation of its activity [35,36]. Inflammasome was
shown to be activated by diverse factors. For example, in injured
tissues, it is activated by danger-associated molecular patterns
(DAMPs), the stress-induced molecules that are released from
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[64,65]. Significantly, inflammasome activation in brain astrocytes
and neurons is implicated in the pathology of brain trauma and
thromboembolic stroke [26,27,66]. However, in other cell types
such as in monocytes, the active role of Panx1 in regulating
inflammasome activity is currently under debate [22,49,67].
Production of mature interleukins requires activation of gene
expression and subsequent processing of the precursor proteins by
caspase-1. Several lines of experimental evidence indicated that
Panx1 is involved in both these processes. First, transcriptional
activation of interleukin precursors via MyD88/NF-kappaB
pathway required stimulation of PRRs, for example the NOD-
like receptors, which are intracellular and require cytosolic
delivery of extracellular DAMPs [66,68]. According to Kanne-
ganti and co-authors [35], such a delivery occurs through the
Panx1 channel. Second, activation of caspase-1 was shown to
require the direct interaction between Panx1 and components of
inflammasome in brain cells [23,63]. The model in which Panx1
contributes to both transcriptional and post-translational activa-
tion of IL-1b by inflammasome, is consistent with our results
(Fig. 4) showing that Panx1 is essential for IL-1b processing and
production in the retina. Interestingly, it was previously reported
that blockade of caspase-1 by intravitreal injection of the selective
peptide inhibitor provided a similar level of neuroprotection
against retinal IR as Panx1 ablation in our experiments [69].
Taken together with previously published findings, our study of
inflammasome in WT and Panx1 knockout mice show that 1)
inflammasome activation is a novel neurotoxicity pathway in
retinal IR and 2) inflammasome activation is facilitated by Panx1.
In conclusion, our results show that Panx-1 mediates neuronal
IR injury through a mechanism that involves acute permeation of
plasma membrane and activation of inflammasome. Our findings
demonstrate that this pathway is intrinsic for RGCs. Membrane
permeation via Panx1 contributes to acute injury by mediating
ionic and metabolic disbalance and triggers long-term toxicity
mechanisms such as cytokine production by the neuronal
inflammasome. Panx1 ablation effectively suppresses inflamma-
some and IL-1b production in vivo in post-ischemic RGCs, which
correlates with neuroprotection.
Materials and Methods
Animals
All experiments and post-surgical care were performed in
compliance with the NIH Guide for the Care and Use of
Laboratory Animals and according to the University of Miami
IACUC approved protocol. Wild type (WT) animals used in our
experiments were 2–3 months old male mice of C57BL/6
background; 6 animals per group). Panx1
fl/fl mouse line with
three LoxP consensus sequences integrated into Panx1 gene was
generated in collaboration with the transgenic facility of the
National Institute of Child Health and Development (Bethesda,
MD), using our own recombinant DNA constructs. Knockout
mice with global (CMV-Cre/Panx1) and neuron-specific condi-
tional (Thy1-Cre/Panx1) inactivation of Panx1 were bread in the
University of Miami facility. Retinal tissues for immunopanning
were obtained from neonatal P5–P7 pups. ‘‘Floxed’’ mouse lines
were generated at the NIH NICHD Transgenic Mouse Core
Facility and transferred to the UM DVR for further breeding with
Cre-expressing lines. These mice were back-crossed to C57Bl6
background for at least 5 generations prior to experiments. Mice
were housed under standard conditions of temperature and
humidity, with a 12-hour light/dark cycle and free access to food
and water.
Isolation of primary RGCs
P5–7 old pups were euthanized according to the University of
Miami IACUC approved protocol, eyes were enucleated and
retinas were mechanically dissected out. RGCs were isolated
according to the two-step immunopanning method. Briefly, the
whole retinas were incubated in papain solution (16.5 U/ml) for
30 min. In the next step macrophage and endothelial cells were
removed from the cell suspension by panning with the anti-
macrophage antiserum (Axell Accurate Chemical Corp., West-
bury, NY). RGCs were specifically bound to the panning plates
containing anti-Thy1.2 antibody, and unbound retinal cells were
removed by washing with DPBS. Purified RGCs were released by
trypsin incubation and grown in Neurobasal/B27 media (Invitro-
gen, USA).
Transient retinal ischemia-reperfusion (IR) model
After anesthesia with intraperitoneal ketamine (80 mg/kg) and
xylazine (16 mg/kg), pupils were dilated with 1% tropicamide–
2.5% phenylephrine hydrochloride (NutraMax Products, Inc.,
Gloucester, MA), and corneal analgesia was achieved with 1 drop
of 0.5% proparacaine HCl (Bausch & Lomb Pharmaceuticals,
USA). Retinal ischemia was induced by increasing intraocular
pressure (IOP) above cystolic blood pressure (to 120 mm Hg) for
60 minutes. IOP was elevated by direct cannulation of the anterior
chamber of the eye a 33-gauge needle attached to a normal (0.9%
NaCl) saline-filled reservoir raised above the animal. The
contralateral eye was cannulated and maintained at normal IOP
to serve as a normotensive control. Complete retinal ischemia,
evidenced by a whitening of the anterior segment of the eye and
blanching of the retinal arteries, was verified by microscopic
examination. After needle removal, erythromycin ophthalmic
ointment (Fougera & Atlanta, Inc., Melville, NY) was applied to
the conjunctival sac. Mice were sacrificed in 7 or 14 days after
reperfusion by CO2 inhalation under anesthesia.
Oxygen/glucose deprivation (OGD) model
After replacement of the media with fresh glucose, amino acids,
vitamins and sodium pyruvate-free Neurobasal media with B27
supplements (Invitrogen, USA), RGCs were exposed to hypoxia by
replacing of the Neurobasal media with glucose-free OGD media
(Hanks’ balanced salt solution with sucrose substituting glucose,
deoxygenated by 1 h bubbling with nitrogen). Cells were placed
into hypoxic chamber (BioSpherix) for 4 h at 37uC, after which
the culture medium is then changed for fresh Neurobasal/B27
media, 4 or 24 h incubation in a 5% CO2 atmosphere at 37uC
(‘‘reperfusion’’ phase). For real-time imaging in RGC cultures,
cover slips with attached cells were placed into class-bottom
microscopy chambers (Lab-Tek II Chamber Slide). To achieve
OGD conditions in these chambers, normoxic media was
substituted with the deoxygenized glucose-free media, oxygen
was removed by continuous nitrogen bubbling through a circular
perforated microtube line glued to the bottom. Each chamber has
been calibrated and tested by direct O2 measurements with
OxyLab pO2 oxygen sensor (Oxford Optronix Ltd.) to achieve
pO2,5 mmHg (time ‘‘0’’ for real-time recordings) 10 minutes
after the media change (see Fig. S8 for the pO2 kinetics in the
chamber with nitrogen bubbling).
Dye transfer tests
Media, cells or tissues were loaded with membrane-impermeable
Calcein 488 AM fluorescent dye (491 nm excitation/509 nm
emission). RGCs were plated at a density of 8610
4 cells/well on 24-
well plates with 12 mm glass coverslips pre-coated with poly-L-lysine
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Retinas were dissected into Neurobasal/B27 media, flat-mounted
on the glasses bottoms pre-coated with Cell-Tek Cell and Tissue
Adhesive (BD Biosciences) and stored in oxygenated chambers at
32uC prior to labeling. For dye loading, cells and whole retinas were
incubatedwith5 mM calcein-AM488 in artificialcerebrospinal fluid
(ACSF, contains (in mM) 150 NaCl, 10 glucose, 5 KCl, 2 CaCl2, 1
MgCl2, 10 HEPES at pH 7.4) for 30 min at 37uC in humidified
incubator under 5% CO2. Cells were washed with ACSF solution
three times to remove the extracellular calcein-AM. The coverslips
with calcein-loaded cells were removed and transferred into glass-
bottom hypoxia chamber for OGD challenge and the fluorescence
imaging analysis. After loading, the chambers with retina whole-
mounts were placed into hypoxic chamber (BioSpherix) for
30 minutes at 37uC in OGD solution. Cells and retinas were
imaged at spectroscopic Leica TCP AOBS SP5 confocal micro-
scope (Leica Microsystems, Exton, PA). All the images from each
experiment were captured under identical microscope settings on
the same day and further analyzed using Leica image analysis
software. The fluorescence intensity values from 50 individual cells
in each experiment (n=3) were determined by real-time recording
using Leica proprietary image analysis software, the mean values
and standard error (SE) were calculated. Single cell calcein dye
leakage dynamics were recorded using 10 minutes after media
change and the beginning of N2 bubbling as t=0. The OGD
solution, containing (in mM) 150 NaCl, 10 Sucrose, 5 KCl, 2
CaCl2, 1 MgCl2, 10 HEPES at pH 7.4, was de-oxygenated by N2
bubbling for at least 1 hr before experiments. To normalize for the
effects of photobleaching, the recorded intensity values were
compared to the signal decline in the control baseline curve,
recorded from similarly processed but untreated (normoxic) cells,
where the changes in fluorescence intensity were due to photo-
bleaching. Individual retinas were sampled randomly to collect a
total of 20 images located at the same eccentricity in the four retinal
quadrants, using a 206 objective lens. The fluorescence intensity
values from 20 images in each experiment (n=3) were determined
using the Leica software.
Calcium imaging
Calcium imaging was performed on acutely isolated neonatal
(P7) retinal ganglion cells, as described previously [70]. One-day
old cultures on laminin-coated coverslips were incubated in
Neurobasal media containing 1 mM fura-2AM for 60 minutes at
37 degrees C in the dark. This was followed by a 30 min wash in
dye-free ACSF media to permit de-esterification of fura-2AM. The
cover slips were then secured in a flow chamber and mounted on
the stage of a Nikon TE2000 inverted fluorescence microscope.
The cells were perfused with ACSF media and subjected to OGD
treatments as required by the experiment. Images were collected
using 206UV objective lens in real time every twenty seconds for
60 minutes. The excitation wavelengths were 340 and 380 nm
provided by a 150 W Xenon arc lamp (DG4, Sutter Instruments)
and the emission was set at 510 nm. Free Ca
2+ concentration was
determined from the fluorescence measurements using the fura-2
Ca
2+ imaging calibration kit (Molecular Probes) according to
manufacturer’s instructions. Data acquisition and F340/F380
ratio calculations were performed using MetaFluor software using
regions of interest (ROIs) encompassing individual RGCs at 363
binning. Background fluorescence was measured in similarly sized
ROIs in neighboring areas devoid of cells and subtracted from
ROI readings. OGD conditions for real time imaging were
achieved by replacing with oxygen-free, glucose-free ACSF media
(equivalent amount of sucrose was added to maintain osmolarity)
and constant bubbling of media and chamber with N2.I n
addition, to ensure full blockade of glycolysis in shallow perfusion
chamber, 10 mM 2-deoxyglucose and 1 mM KCN were added as
described earlier [71]. Glutamate (100 mM) was added at the end
of each individual experiment to identify responsive live cells; the
addition of 10 mM 2-deoxyglucose and 1 mM KCN in full ACSF
media not induce any responses in RGCs (data not shown).
Antibodies
Three different species of antibodies raised against the C-
terminal portion of Panx1 were used in this study: affinity purified
rabbit anti-Panx1 CT-395(Px-34) antibodies [38] provided by Dr.
D.W. Liard (University of Western Ontario, Canada) and rabbit
polyclonal anti-human Pannexin1 antibodies purchased from
Chemicon, Inc and AbnOvation, Inc. We used 1:1000 dilution
for immunohistochemistry (IHC) and 1:5000 for western blot. The
rabbit polyclonal antibodies against ASC and NALP1 proteins
were provided by Dr. Rivero Vaccari. The following commercially
available antibodies were used: anti-caspase-1 (Abcam), anti-IL-1b
(Cell Signaling Technology), anti-XIAP (BD Transduction Labs);
anti-GFAP (Sigma), and anti-CD11b (Millipore), anti-Neuronal
Class III b-Tubulin (Covance). Secondary species-specific fluores-
cence AlexaFluor dye-labeled antibodies for confocal were
purchased at Invitrogen/Molecular Probes, USA.
RGCs loss
The analysis of the RGCs loss in the inner retina was performed
using a specific anti-ClassIIIb-Tubulin staining.Whole retinas were
flat-mounted, coverslipped and specific fluorescence in the inner
retina was imaged. To avoid topological irregularities, stacks of 5
serial images collected for depth 0–30 mm were collapsed to
generate the ‘‘maximum projections’’ (standard feature of the Leica
LAS AF software), where all imaged cells appear in sharp focus.
These images were used for RGC counts with MetaMorph
(Universal Imaging Co., USA) software, after image thresholding
and manual exclusion of artifacts. Individual retinas were sampled
randomly at 20 random fields in three regions/four retinal
quadrants at the same eccentricities (5 at 0.5 mm, 10 at 1.0 mm
and 5 at 1.5 mm from the optic disk) using 206objective lens.RGC
loss was calculated as percentages of b-Tubulin -positive cells in
experimental eyes relative to sham-operated contralateral control
eyes that was cannulated but maintained at normal IOP. The data
from five animals were averaged for each group and genotype.
Neuronal death assay
The percentages of necrotic and apoptotic cells after OGD
challenge were determined using the Vybrant Apoptosis Assay Kit
#2 (Invitrogen, USA). Cells were imaged using a Leica TCP SP5
confocal microscope and counted using Metamorph imaging
software. The percentage of necrotic cells (Annexin V and PI) and
apoptotic cells (only Annexin V) relative to the total number of
cells was determined for each of ten images.
Supplement Methods
We used standard methods for quantitative RT-PCR, Western
blot, immunohistochemistry and statistical analyses (see Methods
S1). The sequences of PCR primers are provided in Table S2.
Supporting Information
Table S1 RGC density in retinas of different genotypes.
(DOC)
Table S2 PCR primers utilized in this study.
(DOCX)
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